Connor, Clark & Lunn Investment Management Ltd. Fulgent Genetics, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 305,180 shares of FLGT stock, worth $7.28 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
305,180
Previous 249,659
22.24%
Holding current value
$7.28 Million
Previous $4.22 Million
43.78%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding FLGT
# of Institutions
187Shares Held
18.3MCall Options Held
185KPut Options Held
24.8K-
Black Rock Inc. New York, NY3.92MShares$93.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.44MShares$34.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$27.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$27 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA1.12MShares$26.7 Million0.05% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $722M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...